| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
38,323 |
36,340 |
$4.40M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,689 |
14,781 |
$1.95M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,072 |
14,422 |
$1.57M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,037 |
4,636 |
$758K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,867 |
1,741 |
$437K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,771 |
2,567 |
$377K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
17,879 |
15,847 |
$165K |
| 64483 |
|
342 |
289 |
$146K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
455 |
427 |
$123K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
453 |
434 |
$67K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,809 |
9,089 |
$56K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
325 |
301 |
$53K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
273 |
258 |
$52K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,679 |
2,536 |
$30K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
178 |
153 |
$30K |
| 80053 |
Comprehensive metabolic panel |
3,507 |
3,257 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
18,293 |
12,524 |
$27K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
216 |
116 |
$23K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
48 |
48 |
$23K |
| 84484 |
|
4,986 |
3,711 |
$22K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
28 |
27 |
$19K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
567 |
565 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
5,125 |
4,755 |
$16K |
| 80076 |
|
2,824 |
2,622 |
$15K |
| 83874 |
|
1,574 |
1,322 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,943 |
6,309 |
$12K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
43 |
42 |
$12K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
812 |
770 |
$11K |
| 85027 |
|
2,026 |
1,429 |
$10K |
| 64635 |
|
19 |
12 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,636 |
7,018 |
$10K |
| 64493 |
|
14 |
12 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
3,616 |
3,403 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
277 |
262 |
$6K |
| 83605 |
|
699 |
561 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,445 |
19,728 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
589 |
587 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
263 |
257 |
$5K |
| 82553 |
|
303 |
267 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
164 |
146 |
$3K |
| 80061 |
Lipid panel |
219 |
211 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
13 |
13 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
171 |
165 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
165 |
157 |
$3K |
| G0378 |
Hospital observation service, per hour |
60 |
26 |
$2K |
| 87510 |
|
79 |
77 |
$2K |
| 81001 |
|
6,996 |
6,517 |
$2K |
| 85379 |
|
377 |
355 |
$2K |
| 64636 |
|
19 |
12 |
$1K |
| 84439 |
|
63 |
60 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,438 |
8,796 |
$1K |
| 83690 |
|
4,417 |
4,105 |
$1K |
| 84703 |
|
4,120 |
3,841 |
$1K |
| 83880 |
|
225 |
209 |
$1K |
| 82607 |
|
36 |
36 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,366 |
2,195 |
$1K |
| 80320 |
|
51 |
42 |
$1K |
| 87660 |
|
79 |
77 |
$933.76 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
812 |
770 |
$933.01 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
348 |
325 |
$920.55 |
| 83525 |
|
26 |
26 |
$844.77 |
| 81003 |
|
4,546 |
4,295 |
$715.55 |
| 81025 |
|
3,750 |
3,551 |
$622.72 |
| 82746 |
|
24 |
24 |
$507.68 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
3,436 |
1,818 |
$485.40 |
| 84436 |
|
25 |
23 |
$475.04 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
25 |
24 |
$458.30 |
| 99152 |
|
1,354 |
1,101 |
$447.24 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,636 |
2,348 |
$425.97 |
| 83735 |
|
1,294 |
1,182 |
$372.19 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,078 |
5,674 |
$360.81 |
| 84481 |
|
13 |
12 |
$252.28 |
| 82150 |
|
581 |
534 |
$239.53 |
| 84480 |
|
25 |
23 |
$237.55 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,245 |
1,093 |
$237.30 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
538 |
363 |
$223.48 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,693 |
5,147 |
$220.42 |
| 74022 |
|
102 |
97 |
$188.79 |
| 73610 |
|
26 |
24 |
$110.37 |
| 99153 |
Mod sedat endo service >5yrs |
204 |
160 |
$88.68 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
15 |
13 |
$85.72 |
| 82550 |
|
305 |
269 |
$83.17 |
| 84134 |
|
15 |
13 |
$71.03 |
| 85610 |
|
142 |
104 |
$67.86 |
| 73130 |
|
111 |
108 |
$56.58 |
| 73562 |
|
56 |
54 |
$53.94 |
| 73630 |
|
114 |
110 |
$53.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,742 |
1,569 |
$49.32 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
264 |
215 |
$46.36 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
317 |
297 |
$29.42 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
368 |
351 |
$26.62 |
| J2704 |
Injection, propofol, 10 mg |
847 |
802 |
$21.20 |
| 82947 |
|
91 |
64 |
$17.89 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
971 |
807 |
$14.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,546 |
1,227 |
$13.84 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
69 |
65 |
$10.34 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,945 |
1,828 |
$9.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,473 |
1,148 |
$8.81 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
243 |
229 |
$7.53 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
24 |
24 |
$6.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
102 |
97 |
$6.10 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
143 |
121 |
$1.93 |
| 64484 |
|
12 |
12 |
$0.00 |
| 96376 |
|
90 |
72 |
$0.00 |
| 72040 |
|
27 |
25 |
$0.00 |
| 87480 |
|
79 |
77 |
$0.00 |
| 85730 |
|
27 |
27 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
28 |
26 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
25 |
25 |
$0.00 |
| 72100 |
|
198 |
184 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
78 |
46 |
$0.00 |
| 94664 |
|
58 |
52 |
$0.00 |
| 01999 |
|
12 |
12 |
$0.00 |